Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Cancer Stem Cells 2020

About Conference


Conference Series llc LTD invites all claimants to attend “12th International Conference on Cancer Stem Cell and Oncology Research” which is going to be held during June 15-16, 2020 |Berlin, Germany

The Theme of the meeting is “Innovation in Cancer Research and Projections of Novel Therapeutic Approaches “The two-day conference program includes prompt keynote presentations, Workshops, Oral talks, Poster presentations and Exhibitions.

The  aims of the meeting is to bring together leading academic scientists, researchers and research scholars to interchange and share their experiences and research consequences on all characteristics of Cancer Stem Cells and Oncology Research. It also transports a foremost interdisciplinary stage for researchers, specialists and instructors to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Cancer Stem Cells and Oncology Research.

Cancer stem cells are cancer cells (found inside tumors or haematological cancers) that retain appearances connected with normal stem cell. Cancer Stem Cells are rare immortal cells within a tumor that can both self-renew by dividing and give rise to many cell types that constitute the tumors, and can therefore form tumors. Cscs are therefore tumorigenic perhaps in contrast to other non-tumorigenic cancer cells. Cscs may create tumors through the stem cell processes of self-renewal and differentiation into multiple cell types. Such cells are hypothesized to persist in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors. Hence, expansion of precise treatments targeted at cscs grasps hope for development of existence and superiority of life of cancer patients, particularly for patients with metastatic disease

Target audience

  • Oncologists
  • Radiologists
  • Pathologists
  • Haematologists
  • Surgeons
  • Physicians
  • Nurses
  • Scientists
  • Pharmacologists
  • Delegates from Clinical Research Centre’s
  • Young Researchers.
  • Students

Conference Series Ltd Organizes 2000+ conferences, 500+ workshops and 200+ symposiums on Clinical, Medicine, Pharma and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 500 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

 

 

Welcome Message

  • Conference Series llc LTD welcomes all the attendees, speakers, sponsor’s and other research expertise from all over the world to the "12th International Conference on Cancer Stem Cells and Oncology Research” (Cancer Stem Cells-2020) which is going to be held during June 15-16, 2020 in Berlin, Germany. We are very much honoured to extend to you a warm invitation to attend and share your views and experience on Cancer Stem Cells and therapeutic approaches.

 

  • Conference Series Ltd Organizes 2000+ conferences, 500+ workshops and 200+ symposiums on Clinical, Medicine, Pharma and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 500 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

 

  • We invite you to join us at the Cancer Stem Cells-2020. All members of the Cancer Stem Cells-2020 organizing committee look forward to meeting you in Berlin, Germany.

Tracks and Sessions

 Track1: cancer stem cell

cancer stem cell (csc) conjectures the occurrence of a slight population of unhealthy cells with distinguishing possessions like defence from outmoded radio-chemotherapy regiments and enlarged metastatic impending. Clinically, the powerful hint of cscs has been performed to attach with extended tumour repeat, metastatic spread, and normally very little patient result over numerous malignant development subtypes. Separation of csc’s has been accomplished through the use of cell surface indicators by the useful differences amongst cscs and residual tumour cells have been depicted through growth, departure, and obliging failing actions.

  • Embryonic stem cell
  • Epigenetics     
  • Stem cell therapy
  • Stem cell transplantation

Track2.  Oncology research

The branch of health care regulates safety & efficacy of medications, devices, and diagnostics and also treatments intended for human use is termed clinical research. Oncology is a part of the medicine that deals with the expectation, assumption, and treatment of cancer disease. Existence has been improved because of three primary sections comprising improved corrective accomplishment actions to reduce exhibition to chance elements (e.g., tobacco smoking and liquor utilization) improved transmission of a few tumours (enchanting into deliberation previous finding), and advancements in treatment.

  • Oncogenes
  • Abnormal cell growth
  • Tumours
  • Immuno oncology
  • Nursing oncology
  • Cancer science
  • Surgical oncology
  • Clinical oncology
  • Paediatric oncology
  • Medical oncology
  • Radiation oncology

Track3. Stem cells

Stem cells are cells that can differentiate into other types of cells, and can also divide in self-renewal to produce more of the same type of stem cells. They are found in multicellular life forms. In mammals, there are two wide kinds of stem cells: embryonic stem cells, which are isolated from the internal cell mass of blastocysts, and adult stem cells, which are found in different tissues.

  • Tissue regeneration
  • Research in stem cell
  • Cancer cure using stem cell
  • Neural stem cells

Track4. Stem cell therapy

Important microorganisms are the body's rough constituents cells from which each one cell with specific limitations are shaped. New stem cells either finish up being new indistinguishable cells with a more precise limit for occurrence: platelets, mind cells, heart muscle cells or bone cells. No additional cell in the body has the contained capability to create new cell types.

  • Lymphoma cancer
  • Immune cell therapy
  • Acute myelomonocytic leukaemia
  • Acute lymphoblastic leukaemia
  • Acute megakaryocytic leukaemia
  • Allogeneic transplantation.
  • Advances in bone marrow stem cell

Track5. Stem cell renewal

In many tissues, mammalian growing is connected with a decrease in the replicative and effective limit of physical immature microorganisms and other self-recharging sections. Therefore sympathetic the evidence of this deterioration is a notable impartial of maturing research. . Such practices include activities to shield indistinguishable organisms from age-advancing damage, to 'revive' establish microorganisms using pharmacologic authorities that reasonable maturing impelled modifications in flagging, and to replace lost undeveloped cells through reformative drug methods. Some development has been made in every one of these fields in the course of the most recent year and a half incorporating advances in the group of sponsor specific highest indistinguishable organisms through provoked legate, gains in our command of how tumour silencer weakening is controlled in self-restoring sections to direct maturing, and further show of extracellular 'milieu' factors that trouble untrained cell work with age.

  • Regenerative medicine and ips    
  • Somatic self-renewal and aging
  • Somatic stem and progenitor cell aging

Track6. Cancer biomarkers

A cancer biomarker mentions to a component or technique that is revealing of the occurrence of cancer in the body. A biomarker may be a particle unrestricted by an occurrence of tumour or a precise reaction of the body to the occurrence of cancer. Cancer biomarkers are typically biological molecules originate in blood, other body fluids, or materials that are a sign of a normal anomalous procedure, or of an ailment or disease. Genetic, epigenetic, proteomic, glycaemic, and imaging biomarkers can be used for cancer analysis, prediction and epidemiology. The most auspicious use of biomarkers nowadays is to classify which ways a patient’s cancer may or may not counter to, so many medicinal companies were creating different sort of biomarkers. So, it plays a vital role in the treatment in cancer.

  • Rapd
  • Transciptomic biomarkers
  • Proteomic biomarkers
  • Rflp

Track7. Types of cancer

Cancer type includes carcinoma, sarcoma, tumours got from epithelial cells. This assembly includes a huge number of the most extensively documented malignancies and include almost each one of those in the special, prostate, lung, pancreas and colon.

  • Lung cancer & breast cancer
  • Bladder cancer & stomach cancer
  • Liver cancer & melanoma skin cancer
  • Bowel cancer & cervical cancer
  • Brain tumours & prostate cancer
  • Non-hodgkin lymphoma & bone cancer
  • Colorectal cancer & pancreatic cancer
  • Blood cancer & lymphomas
  • Kidney cancer & ovarian cancer

Track8. Cancer causes

There can be numerous reasons for cancer cells development and progress. Numerous influences can effect superiority variations, for example, smoking, radiation, infections, cancer causing artificial mixtures (cancer-causing agents), heftiness, hormones, infinite exacerbation and a nonappearance of movement.

  • Radiation effect
  • Lifestyle effects
  • Hereditary malignancies

Track9. Cancer stages

Launching can be "investigational" or "anxious." clinical establishment is based on the after effects of the examinations done previous to the medical process for example:  physical investigations and imaging filters. Anxious establishment based on what is originate through the medical process. Clinical stage is repeatedly confirmed by a lowercase "c" before the tnm alliance. The compulsive stage is confirmed by a lowercase "p."

  • Tnm framework organizing
  • Post therapy
  • Recurrence
  • Autopsy

 track10. Nanotechnology in cancer

Cancer nanotechnology is a measure of nanotechnology which contracts with numerous methods, apparatus’s also known as nano-materials to the examination and management of cancer. It is the division of nanotechnology that uses nano-science and nano vectors to remedy or break cancer cells and their development

  • Cancer treatment
  • Immunotherapy
  • Nanotechnology in cancer cure

Track11. Hemato-oncology and blood cancer

Also known as leukaemia this is a cancer of blood forming tissues which also involves bone marrow. There are many types of this cancer like acute lymphoblastic leukaemia, chronic lymphocytic leukaemia and many others. This type of cancer mainly develops due to some changes which happens by mistake while the development of the blood cell.

  • Multiple myeloma
  • Hodgkin lymphoma

Track12. Radiation oncology and skin cancer

It is one of the three primary specialities in which the other two are surgical and medical oncology which are basically involved in the treatment of cancer. In this penetrating and irritant rays are used to control and kill the malignant cells. While the skin cancer is the abnormal growth of the cell present in skin in which the most common type is associated with squamous cell and basal cell. Furthermore, treating of skin cancer is mainly with the help of radiation therapy than the other two.

Track13. Neuro oncology

neuro-oncology is the study of brain and spinal cord neoplasms, numerous of which are very hazardous and dangerous (astrocytoma, glioma, glioblastoma multiforme, ependymoma, pontine glioma, and brain stem tumors are amongst the numerous examples of these). Amongst the malicious brain cancers, gliomas of the brainstem and pons, glioblastoma multiforme, and high-quality astrocytoma are amid the most horrible.

Track14. Cancer genomics

It is a study of the dna sequencing, gene expression and other type of inheritance materials which are responsible for the initiation of the cancer in a human being; moreover it is a vast study because it helps to know the factors which are responsible for the creation of cancer.

Track15. Epigenetics of cancer stem cells

epigenetic instruction of the genome is one of the prime worth by which genomic encryption is changed to switch cellular developing chain of command. Epigenetic appliances such as histone alterations, dna methylation, chromatin transformation and even variations in noncoding rnas comprising  together direct the epigenome background that command the result of cell fate requirement deprived of changes to the dna arrangements. Such variations in the genome are significant through regular mammalian growth and escs discrepancy. Prominently, gene manifestation contours alteration throughout cellular distinction according to not only a linkage of record aspects but also the “epigenomic setting” of the cell.

Track16. Recent advances in cancer stem cell

Cancer stem cells are one of the causes for the relapse of cancer cells and metastasis. They have drug confrontation in contradiction of most chemotherapeutic agents. Cancer stem cells are also liable for tumor cell heterogeneity and cause negligible residual disease. In order to attain whole deterioration of tumors, cscs have to be targeted. Current developments in immunotherapies have shown promising outcomes in preserving cancer, which are also relevant to target cancer stem cells. Cscs express immune indicators and display precise immune appearances in numerous cancers, which can be used in immunotherapies to mark cscs in the tumor microenvironment. Lately, numerous policies have been used to target cscs. Adaptive t-cells, dendritic cell (dc)-based vaccines, oncotic viruses, immune checkpoint inhibitors, and combination therapies are now being used to target cscs.

Track17. Stem cell and regenerative medicine

stem cells have an ability for self-renewal and ability of propagation and discrepancy to many cell families. They can be categorized into embryonic stem cells and non-embryonic stem cells. Mesenchyme stem cells show excessive potential in numerous studies and clinical trials. Regenerative medicine aims at aiding the body to form new useful tissue to swap lost or flawed ones. Regenerative medicine encompasses the use of tissue engineering and stem cell technology.

Track18. Advances in stem cell and their niches

Stem cell niches are vigorous microenvironments that equilibrium stem cell movement to preserve tissue homeostasis and reparation through the generation of an organism. The growth of plans to screen and trouble niche constituents has provided vision into the receptive nature of the niche and proposals a framework to uncover how disturbance of normal stem cell niche function may donate to aging and disease onset and development. Developments in stem cells and their niches" reports new developments in the field counting new data on disease, and scientific applications

Track19. Therapies targeting cancer stem cells

Targeting the biomarkers present on the surface, signalling pathways which primarily regulates cancer stem cells self-renewal and differentiation and also drug-efflux pumps which are involved in the apoptosis resistance and micro-environmental signals that endure cscs growth. In order to grow well-organized treatments that can induce a long-lasting clinical response inhibiting tumor relapse it is significant to progress drugs that can exactly target and disregard cscs.

  • Chemotherapy
  • Radiotherapy

Track20. Advancement in developmental biology and stem cells

Progressive biology (including embryology) is planned as "the stem cell of biological corrections." heredities, cell science, oncology, immunology, transformative constituents, neurobiology, and outlines science every have its inheritance in determinative science. In addition, influential science keeps on moving on, growing off more imparts, while allotment its very own character. While its comparative controls discrete into sciences with a limited arrangement of standards, examples, and systems, formative science stays incredible, pluripotent, and generally undifferentiated. In numerous orders, particularly in transformative science and oncology the progressive opinion of view is being reaffirmed as a serious research program.

  • Tissue compartmentalisation
  • Oncogenic perturbation of stem cell behaviour
  • Compartmentalisation and heterogeneity beyond the epidermis
  • The emergence of cellular heterogeneity within the psu
  • The psu and tissue compartmentalisation

Track21. Clinical research and trials in stem cells and cancer

Scientific initiations are approximately professed for actual developments in cancer behaviour since of evolving advanced medicines to prevent or help manage graft-versus-host disease. Graft-versus-host disease, a representative and imaginably dangerous reaction of stem cell relocates in which contributor benign cells attack solid persistent cells and tissues generating cancer vaccination systems for use together with transplant to invigorate the graft-versus- leukaemia impression and boundary condition relapse. Graft-versus-leukaemia (gvl) impact healing impression in which relocated untouchable cells attack excess leukaemia or extra tumour cells.

  • Cellular therapy
  • Tissue regeneration
  • Drug discovery
  • Stem cell transplantation

Track22. Advanced in tissue regeneration

Tissue engineering is a rational arena and portrayed as sympathetic the standards of tissue and its development by nearby conversation of inadequate tissue for clinical use. Tissue construction contracts around the examination of mixing of cells, structuring, materials and practices, biochemical sections to promote characteristic tissues. It includes the application of scaffolds to shape practical tissues and organs, which can be entrenched, again into the sponsor, have with the use of many erection and materials methods alongside some semi-circular elements. It is documented with in excess of one branch which relates constructional evidences and life science ideas to the progression of normal alternates which can improve or re-establish all the qualities of an organ.

  • Tissue engineering
  • Regenerative medicine
  • Bio materials
  • Scaffolds
  • Tissue regeneration

Track23.  Cancer stem cell treatments

Cancer treatments in contradiction of tumour, chemo-and radiotherapy, have numerous limits that prompt treatment dissatisfaction and disease recurrence. These cells are related with tumour creation, sustenance, metastasis and recurrence. Therefore, with the end goal to make creative drugs that can quick a reliable scientific reaction prevention tumour relapse it is vital to create drugs that can particularly target and dispose of cscs. On-going distinguishing resistant of surface markers and understanding of atomic element is connected with csc phenotype, helped with the plan of feasible medicines

  • Gene treatment
  • Epigenic alternatives
  • Radiation treatments

Track24. Cancer cell plasticity

Human cells are very plastic. Plasticity endows cancer cells with the capacity to shift dynamically between a differentiated state, with limited tumorigenic potential, and an undifferentiated or cancer stem-like cell (csc) state, which is responsible for long-term tumor growth. This is the ability of cancer cell to change their physiological properties to resist many changes of the therapy whether it is associated with pre-treatment or the post treatment and in addition to this it generates and spread potential tumour around the whole body.

Track25. Breast cancer stem cell

breast cancer is the most prevalent type of cancer among women worldwide; cancer stem cells are a minute population of cells of solid tumors which show self-renewal and differentiation properties as well as tumorigenic potential. And play a critical role in the self-renewal and differentiation of cancer stem cells in breast cancer.

Market Analysis

About cancer stem cell therapeutics market

Cancer is one of the most communal reasons of deaths crosswise the biosphere. The extraordinary occurrence of numerous kinds of cancer, such as breast cancer, bladder cancer, lung cancer, leukemia, pancreatic cancer, as well as prostate cancer, has enlarged the death rate crosswise the world. Nations such as Hungary, Netherlands, Denmark, and Croatia have observed a growth in the volume of cancer circumstances over the past few years. The growing instances of cancer-related morbidity across the world will fuel the request for cancer stem cell therapeutics and determination the development of the worldwide cancer stem cell treatment marketplace size at a CAGR of over 11% throughout the projection dated. The global cancer stem cells market size was valued at USD 679.5 million in 2016the global cancer stem cell therapeutics market to grow at a CAGR of over 11%% during the period 2019-2023.currently, oncology therapeutics has entered a new era with conventional therapies such as radiotherapy, chemotherapy, & surgeries on one side and stem cell therapies on another side.

Key Players for Global Cancer Stem Cells Market Report-

  • Cellerant Therapeutics, Inc.
  • Celularity Inc.
  • Gamida Cell Ltd.
  • Nohla Therapeutics, Inc.
  • Sumitomo Dainippon Pharma Co. Ltd.
  • Abbvie Inc.
  • Athersys Inc.
  • AVIVA Biosciences
  • Beckton Dickson and Company,
  • Epic Sciences
  •  Immunocellular Therapeutics Ltd
  •  JCR Pharmaceuticals
  • LONZA Group AG
  • Thermo Fischer Scientific 

Importance & Scope

Cancer is second leading cause of death worldwide. Treatments that work for some cancers don’t work for the others and sometimes those treatments simply stop working and only a global search for answers will help us get to grip this disease. The conference will provide with an opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of oncology.

Cancer stem cells 2020 will also explore the new ideas and concepts on global scale and the topics Cancer Science & Therapy, Cancer Cell Biology, Organ-Defined Cancers, Tumour Science, Cancer Genetics, Clinical Cancer Research, Cancer & Tumour Immunology, Cancer : Genomics & Metabolomics, Targeted Cancer Therapy, Stem Cell Therapy, Cancer Biomarkers, Cancer Nanotechnology, Cancer Treatment and Therapeutics, Cancer Clinical Trials, Cancer Case Reports, Cancer Drug Diagnostics & Therapeutics, Precision Medicine & Cancer Therapy, Cancer Management & Prevention, Economic Impact of Cancer Therapy.

Cancer Diagnostic Market:

 By Technology:

A.    Platform Based:

·         In situ Hybridization

·         Flow Cytometry

·         Next-generation Sequencing

·         Microarrays

·         Others

B. Instrument Based:

·         Biopsy

·         Mammography

·         PET

·         Ultrasound

·         MRI

·         CT

The global stem cells market extent was estimated at USD 8.65 billion in the year 2018 and is expected to expand at a CAGR of 8.8% over the predicted period. According to the Wide Cells Group, between the years 2005 and 2013, there has been a 300% rise in the number of diseases that can be cured by stem cells.

Stem Cell Therapy Market revenue will reach $15 billion by 2025. Oncology segment held over 39% revenue in 2019. The global stem cell therapy market is expected to witness a CAGR of 10.6% during the forecast period 2019-2024, and is also predicted to reach USD 214.5 million by the end of 2024.

 

 

 

 

To Collaborate Scientific Professionals around the World

Conference Date June 15-16, 2020

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Supported By

Journal of Oncology Research and Treatment Journal of Integrative Oncology Journal of Cancer Science & Therapy

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner